EXEL
Exelixis, Inc.
Stock
$58.39+0.45 (+0.78%)Close Oct 2, 2026
- Research and development, FY2025
- $825M
- YoY, FY2025
- −9.4%
- 5-year CAGR
- +8.5%
- 10-year CAGR
- +24.0%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| FY2025 | $825M | −9.4% |
| FY2024 | $910M | −12.8% |
| FY2023 | $1.0B | +17.1% |
| FY2022 | $892M | +28.6% |
| FY2021 | $694M | +26.6% |
| FY2020 | $548M | +62.6% |
| FY2019 | $337M | +84.9% |
| FY2018 | $182M | +62.5% |
| FY2017 | $112M | +16.9% |
| FY2016 | $96M | −0.4% |
| FY2015 | $96M | −49.0% |
| FY2014 | $189M | +5.8% |
| FY2013 | $179M | +38.7% |
| FY2012 | $129M | −17.8% |
| FY2011 | $157M | −25.6% |
| FY2010 | $211M | −10.2% |
| FY2009 | $235M | — |